Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | MHRA Buyer Organisation |
| Main Category: | Goods |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | £400,000 |
| Release Date: | 27 September 2022 |
| Application Deadline: | 15 August 2022 |
| Contract Start Date: | 22 September 2022 |
View Original Notice
Access the full notice on the official portal
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award value: | £400,000 |
| Award decision date: | 22 September 2022 |
| Award status: | Active |
The required genetic analyser will be used to undertake both Sanger Sequencing and Fragment Analysis including the batch release of vaccines, as part of a wider sequencing core function. The system will need to be used under the Quality control system. Actual consumable and operational spend will depend on actual work flows and demand.
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
15 August 2022
Closed
Estimated Value
£400,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Contract End Date: |
| 23 September 2027 |
| Contract Duration: | 5.1 years |
| Procurement ID (OCID): | ocds-b5fd17-fd027745-e40c-4c6c-984c-89023fbe0ea0 |
| Notice Reference: | 6c211373-6a3d-4c37-a2b3-19d7449aee17-575040 |